> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Releases New Ranitidine Contamination Test
- URL: https://www.fdaweb.com/fda-releases-new-ranitidine-contamination-test/
- Published: 2019-10-24T12:00:00.000Z
- Updated: 2026-09-15T01:58:46.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145329

FDA says it is releasing a second liquid chromatography-mass spectrometry method for use in detecting and quantifying NDMA in ranitidine. The agency also announced two ranitidine recalls.

An agency [statement](https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine?utm%5Fcampaign=FDA%20releases%20add%20NDMA%20testing%20method%20%26%20alerts%20HCPs%20%26%20patients%20to%20mult%20vol%20recalls%20of%20ranitidine&utm%5Fmedium=email&utm%5Fsource=Eloqua) says FDA is using the new method to test potential NDMA-containing ranitidine samples. The method uses a more widely available technology than the first method FDA released, the statement says.

Recalls of ranitidine were announced for prescription and over-the-counter tablets and capsules manufactured by Dr. Reddy’s and possibly labeled for retailers such as Walgreens, Walmart, CVS, Target, and Kroger, and for Sanofi due to possible NDMA contamination.

The agency statement says patients taking prescription ranitidine should talk to their healthcare professional about other treatment options, while those taking over-the-counter products, indicated for preventing and relieving heartburn associated with acid indigestion and sour stomach, could consider using other OTC products. Preliminary tests of OTC Pepcid. Tagamet, Nexium, Prevacid, and Prilosec found no NDMA in the samples, FDA says.